Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
2002 1
2003 3
2004 1
2012 1
2016 3
2017 1
2019 1
2020 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators. Eikelboom JW, et al. N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28844192 Free article. Clinical Trial.
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E; HOPE-3 Investigators. Yusuf S, et al. N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27040132 Free article. Clinical Trial.
Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries.
ESCP EAGLE Safe Anastomosis Collaborative and NIHR Global Health Research Unit in Surgery. ESCP EAGLE Safe Anastomosis Collaborative and NIHR Global Health Research Unit in Surgery. Br J Surg. 2024 Jan 3;111(1):znad370. doi: 10.1093/bjs/znad370. Br J Surg. 2024. PMID: 38029386 Free PMC article. Clinical Trial.
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells.
Asperti M, Cantamessa L, Ghidinelli S, Gryzik M, Denardo A, Giacomini A, Longhi G, Fanzani A, Arosio P, Poli M. Asperti M, et al. Pharmaceuticals (Basel). 2019 Sep 2;12(3):129. doi: 10.3390/ph12030129. Pharmaceuticals (Basel). 2019. PMID: 31480699 Free PMC article.
Ribonucleotide reductase (RR) is the rate-limiting enzyme that controls the deoxynucleotide triphosphate synthesis and it is an important target of cancer treatment, since it is expressed in tumor cells in proportion to their proliferation rate, their invasiveness and poor progno …
Ribonucleotide reductase (RR) is the rate-limiting enzyme that controls the deoxynucleotide triphosphate synthesis and it is an important ta …
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D, Sliwa K, Dans A, Avezum A, Piegas LS, Keltai K, Keltai M, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Parkhomenko A, Khunti K, Toff WD, Reid CM, Varigos J, Leiter LA, Molina DI, McKelvie R, Pogue J, Wilkinson J, Jung H, Dagenais G, Yusuf S; HOPE-3 Investigators. Lonn EM, et al. N Engl J Med. 2016 May 26;374(21):2009-20. doi: 10.1056/NEJMoa1600175. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27041480 Free article. Clinical Trial.
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J, Xavier D, Avezum A, Leiter LA, Piegas LS, Parkhomenko A, Keltai M, Keltai K, Sliwa K, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Accini JL, McKelvie R, Pogue J, Jung H, Liu L, Diaz R, Dans A, Dagenais G; HOPE-3 Investigators. Yusuf S, et al. N Engl J Med. 2016 May 26;374(21):2032-43. doi: 10.1056/NEJMoa1600177. Epub 2016 Apr 2. N Engl J Med. 2016. PMID: 27039945 Free article. Clinical Trial.
The value of (18)F-FDG PET/CT in the assessment of active idiopathic retroperitoneal fibrosis.
Moroni G, Castellani M, Balzani A, Dore R, Bonelli N, Longhi S, Martinelli I, Messa P, Gerundini P. Moroni G, et al. Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1635-42. doi: 10.1007/s00259-012-2144-6. Epub 2012 Jul 17. Eur J Nucl Med Mol Imaging. 2012. PMID: 22801728
In particular, the relationship between SUVmax and CE, the latter calculated from the change in radiodensity (Hounsfield units) between the basal and postcontrast venous portal phases, was evaluated on a three-point scale (0 <20 HU, 1 20-30 HU, 2 30 HU). S …
In particular, the relationship between SUVmax and CE, the latter calculated from the change in radiodensity (Hounsfield units) between the …
First measurement of transferred polarization in the exclusive ep-->e'K+Lambda--> reaction.
Carman DS, Joo K, Mestayer MD, Raue BA, Adams G, Ambrozewicz P, Anciant E, Anghinolfi M, Armstrong DS, Asavapibhop B, Audit G, Auger T, Avakian H, Bagdasaryan H, Ball JP, Barrow SP, Battaglieri M, Beard K, Bektasoglu M, Bellis M, Bennhold C, Bianchi N, Biselli AS, Boiarinov S, Bonner BE, Bouchigny S, Bradford R, Branford D, Briscoe WJ, Brooks WK, Burkert VD, Butuceanu C, Calarco JR, Carnahan B, Cazes A, Cetina C, Ciciani L, Clark R, Cole PL, Coleman A, Cords D, Corvisiero P, Crabb D, Crannell H, Cummings JP, DeSanctis E, Degtyarenko PV, Denizli H, Dennis L, DeVita R, Dharmawardane KV, Dhuga KS, Djalali C, Dodge GE, Doughty D, Dragovitsch P, Dugger M, Dytman S, Dzyubak OP, Eckhause M, Egiyan H, Egiyan KS, Elouadrhiri L, Empl A, Eugenio P, Fatemi R, Fedotov G, Feuerbach RJ, Ficenec J, Forest TA, Funsten H, Gaff SJ, Gai M, Garçon M, Gavalian G, Gilad S, Gilfoyle GP, Giovanetti KL, Girard P, Golovach E, Gordon CI, Griffioen K, Grimes S, Guidal M, Guillo M, Guo L, Gyurjyan V, Hadjidakis C, Hakobyan RS, Hardie J, Heddle D, Heimberg P, Hersman FW, Hicks K, Hicks RS, Holtrop M, Hu J, Hyde-Wright CE, Ishkhanov B, Ito MM, Jenkins D, Kelley JH, Kellie JD, Khandaker M, Kim KY, Kim K, Kim W, K… See abstract for full author list ➔ Carman DS, et al. Phys Rev Lett. 2003 Apr 4;90(13):131804. doi: 10.1103/PhysRevLett.90.131804. Epub 2003 Apr 4. Phys Rev Lett. 2003. PMID: 12689277
14 results